NYSE: PEN
Last close prices updated as of
May 26, 2023, 7:00 PM EST
| USD | BATS BZX Real-Time Price
- Last Close 306.5
- Sector Healthcare
- Industry Medical Devices
- Investment Style Mid Growth
- Day Range 303.00 – 308.71
- Year Range 114.87 – 324.38
- Market Cap 11.7245 Bil
- Volume / Avg 254,268.0 / 355,492.8
- Price / Sales 13.16
- Price / Book 11.44
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis PEN
Valuation
Currency in —
Is it the right time to buy or sell?
Is it the right time to buy or sell?
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
About Quantitative Ratings
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Unlock Our Full Analysis With Morningstar Investor
Company Profile PEN
Business Description
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
Penumbra Inc
XNYS: PEN
| AngioDynamics Inc
XNAS: ANGO
| Abiomed Inc
XNAS: ABMD
| Outset Medical Inc Ordinary Shares
XNAS: OM
| |
Price
| 306.50 | 9.29 | — | 21.41 |
Currency
| USD | USD | — | USD |
Change
| +$1.60 (0.52%) | −$0.08 (0.85%) | — | +$1.18 (5.83%) |
Market Cap
| 11.72 Bil | 364.51 Mil | — | 1.05 Bil |
Industry
| Medical Devices | Medical Instruments & Supplies | Medical Devices | Medical Devices |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Penumbra Inc Stock
No. PEN does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
PEN’s market cap is 11.72 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
PEN’s stock style is Mid Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
PEN’s price/sales is 13.16.
Price/sales represents the amount an investor is willing to pay for a dollar generated from
a particular company’s sales or revenues.
PEN’s price/forward earnings is 1802.94.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates.
The lower the Forward P/E, the cheaper the stock.
PEN’s price/book is 11.44.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets,
based on historical, rather than current, valuations. Historical valuations generally do not reflect
a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See PEN’s valuation ratios compared to the Market Index.
PEN’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare PEN’s historical performance against its industry peers and the overall market.